Harvard Bioscience Inc
HBIO· Nasdaq
HBIOHarvard Bioscience Inc
Released Apr 29, 2016, after the close
10-K filed Apr 29, 2016, 120 days after period end · 0001171843-16-009551
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2015 | Q4 2014 | Q4 2013 | Q4 2012 |
|---|---|---|---|---|
| Revenue | $28.37M | $30.36M | $27.85M | $28.25M |
| Net Income | -$17.14M | -$19.00K | -$756.00K | $1.20M |
| EPS Diluted | -$0.51 |
Harvard Bioscience Inc · CIK 1123494 · Engraved from SEC EDGAR
| $0.00 |
| -$0.02 |
| $0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
